Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
Tameris M, Mearns H, Penn-Nicholson A, Gregg Y, Bilek N, Mabwe S, Geldenhuys H, Shenje J, Luabeya AKK, Murillo I, Doce J, Aguilo N, Marinova D, Puentes E, Rodríguez E, Gonzalo-Asensio J, Fritzell B, Thole J, Martin C, Scriba TJ, Hatherill M; MTBVAC Clinical Trial Team. Tameris M, et al. Among authors: marinova d. Lancet Respir Med. 2019 Sep;7(9):757-770. doi: 10.1016/S2213-2600(19)30251-6. Epub 2019 Aug 12. Lancet Respir Med. 2019. PMID: 31416768 Clinical Trial.
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.
Spertini F, Audran R, Chakour R, Karoui O, Steiner-Monard V, Thierry AC, Mayor CE, Rettby N, Jaton K, Vallotton L, Lazor-Blanchet C, Doce J, Puentes E, Marinova D, Aguilo N, Martin C. Spertini F, et al. Among authors: marinova d. Lancet Respir Med. 2015 Dec;3(12):953-62. doi: 10.1016/S2213-2600(15)00435-X. Epub 2015 Nov 17. Lancet Respir Med. 2015. PMID: 26598141 Clinical Trial.
Breaking Transmission with Vaccines: The Case of Tuberculosis.
Gonzalo-Asensio J, Aguilo N, Marinova D, Martin C. Gonzalo-Asensio J, et al. Among authors: marinova d. Microbiol Spectr. 2017 Jul;5(4):10.1128/microbiolspec.mtbp-0001-2016. doi: 10.1128/microbiolspec.MTBP-0001-2016. Microbiol Spectr. 2017. PMID: 28710848 Free PMC article. Review.
Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection.
Dijkman K, Aguilo N, Boot C, Hofman SO, Sombroek CC, Vervenne RAW, Kocken CHM, Marinova D, Thole J, Rodríguez E, Vierboom MPM, Haanstra KG, Puentes E, Martin C, Verreck FAW. Dijkman K, et al. Among authors: marinova d. Cell Rep Med. 2021 Jan 19;2(1):100187. doi: 10.1016/j.xcrm.2020.100187. eCollection 2021 Jan 19. Cell Rep Med. 2021. PMID: 33521701 Free PMC article.
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials.
Arbues A, Aguilo JI, Gonzalo-Asensio J, Marinova D, Uranga S, Puentes E, Fernandez C, Parra A, Cardona PJ, Vilaplana C, Ausina V, Williams A, Clark S, Malaga W, Guilhot C, Gicquel B, Martin C. Arbues A, et al. Among authors: marinova d. Vaccine. 2013 Oct 1;31(42):4867-73. doi: 10.1016/j.vaccine.2013.07.051. Epub 2013 Aug 17. Vaccine. 2013. PMID: 23965219
Recent developments in tuberculosis vaccines.
Marinova D, Gonzalo-Asensio J, Aguilo N, Martin C. Marinova D, et al. Expert Rev Vaccines. 2013 Dec;12(12):1431-48. doi: 10.1586/14760584.2013.856765. Expert Rev Vaccines. 2013. PMID: 24195481 Free article. Review.
74 results